News Center
Before a first IVF cycle at clinics such as HRC Fertility or CCRM Fertility, the medical tests themselves move quickly: bloodwork, an ultrasound, infectious disease screening, and a semen analysis are usually completed within one to two weeks. What actually sets your start date is a second set of requirements: signed informed consent covering embryo disposition, legal verification of every intended parent, psychological evaluation where it applies, and authenticated medical records. Missing paperwork, far more than missing lab values, is what pushes first cycles back.
Every United States clinic builds its pre-cycle panel around a few standard components. The female partner (or the person who will carry the pregnancy) completes ovarian reserve testing, typically anti-Müllerian hormone (AMH) plus an antral follicle count by ultrasound, thyroid function (TSH), blood type and Rh factor, immunity screening for rubella and varicella, and a uterine evaluation such as a saline infusion sonogram. The male partner provides a semen analysis. Both partners complete an infectious disease panel covering HIV, hepatitis B, hepatitis C, and syphilis, and most clinics now add an expanded genetic carrier panel that screens several hundred genes at once; if one partner carries a recessive condition, the other partner's result determines whether embryo genetic testing is recommended.
One regulatory anchor explains why the infectious disease panel is non-negotiable. Under the US Food and Drug Administration's rules for human cells and tissues (21 CFR Part 1271), reproductive tissue is subject to donor screening and testing for communicable disease agents. The same regulation contains a narrow exemption at 21 CFR 1271.90(a): a person providing gametes to his or her own sexually intimate partner is exempt from full donor eligibility requirements. The moment a gamete source sits outside the couple, the full FDA screening package applies, and the clinic's paperwork demands change accordingly. That shift from partner cycle to third-party cycle is where most of the legal requirements described below begin to attach.
Timing matters as much as content. Most clinics treat the infectious disease panel as valid for roughly twelve months, and some shorten that window to six. Reserve tests done abroad are frequently repeated domestically because AMH assays vary between laboratories and countries, so a foreign result may be reviewed but still re-ordered. These tests, however, are the fast part of the process. The slow part is everything that has to be signed, verified, or written by a lawyer before the clinic will open a cycle calendar.
Patients routinely budget two weeks for testing and then discover the consent packet alone can consume a month. United States clinics hand over a stack of forms that runs from a dozen to more than fifty pages, and the pages that generate the most questions, corrections, and follow-up appointments are the embryo disposition forms. These documents are legally significant. Courts have repeatedly treated properly executed consent directives as controlling evidence in later disputes, which is precisely why clinics refuse to start a cycle with unsigned or internally inconsistent forms on file.
A typical disposition section forces a decision on each of the following, usually with a primary and a secondary choice in case the first is unavailable:
The granularity surprises most patients. Some forms ask what should happen if one partner cannot be reached after three documented contact attempts spread over ninety days. Others ask each partner to answer the divorce question in a separate session, without seeing the other's answers, and flag any mismatch for resolution before the cycle can be scheduled. A couple who writes "discarded" on one line and "donated to research" on the other will be called back for a clarification appointment, and that appointment alone can add a week.
Each clinic drafts its own consent packet, and the default wording differs in ways worth comparing line by line. Across the industry you will find two broad patterns. In one pattern, continued storage is the default: fees keep billing and embryos stay frozen until you file a new directive. In the other, the form requires an affirmative annual election, and silence triggers a defined escalation process ending in discard or clinic-defined disposition. Research donation appears as a simple opt-in checkbox at some clinics and as a tiered choice (anonymous research, identifiable research, or no research) at others. HRC Fertility, with multiple California locations, and CCRM Fertility, a Colorado-headquartered network with sites across the country, each maintain standardized packets for their systems, so the specific defaults you sign at one will not necessarily match the defaults at the other. The practical instruction is the same either way: read the disposition page together with the storage fee schedule, and ask the coordinator to point to the exact clause that governs abandonment and non-payment before you sign.
State law, more than clinic policy, decides these disputes, and the leading cases show why clinics now interrogate these clauses one by one. In Davis v. Davis, 842 S.W.2d 588 (Tennessee Supreme Court, 1992), the court held that frozen embryos occupy an intermediate status, neither persons nor ordinary property, and ruled that an ex-spouse's interest in avoiding genetic parenthood prevailed where the couple had made no prior agreement. In Kass v. Kass, 696 N.Y.S.2d 543 (New York, 1999), the court enforced the couple's consent form exactly as written, treating the documented directives as controlling. In J.B. v. M.B., 783 A.2d 616 (New Jersey, 2001), the court recognized a unilateral right to avoid genetic parenthood while giving substantial weight to prior informed consent documents. Read together, the three cases send one message: the form you sign at intake is the document a court will likely enforce years later.
That is why a clinic will walk a couple through the death and divorce clauses verbally, not just collect signatures. Boundary conditions matter here. A form that binds cleanly in New York may be interpreted differently in a state without its own precedent, and a handful of states have statutes touching embryo status directly. Ask two questions before signing: whether the clinic's form has been reviewed under the law of your home state, and whether the clinic requires notarization or witnesses for later disposition changes. Both answers belong in your planning file.
The second underestimated node is legal identity verification. A clinic cannot open a chart for a cycle until every intended parent's legal status is documented, and the document list changes sharply depending on marital status and gamete origin.
A married couple generally provides a marriage certificate, and both spouses sign consents acknowledging parentage of any child born from the cycle. An unmarried couple faces a heavier file. Many clinics require a written parentage agreement drafted by independent counsel before treatment. The statutory basis varies by state; California Family Code § 7613, for example, provides that a person who consents in a signed writing before assisted reproduction to parenthood of a resulting child is a legal parent, which gives unmarried couples in that state a clear written instrument to rely on. In states without an equivalent statute, the clinic may ask for a court order or an adoption plan before releasing a cycle calendar. The charting rule is absolute in practice: if the parentage document is missing, the cycle is not entered into the schedule, regardless of how complete the medical workup is.
Third-party cycles stack three document layers on top of the standard packet. First, the gamete source must complete FDA donor eligibility screening under 21 CFR Part 1271, including a medical history interview, physical examination, and communicable disease testing; the intimate-partner exemption no longer applies. Second, the clinic requires the donor's consent documentation, including any limits on identity release and an affidavit or record confirming the donor's parental rights are terminated by agreement. Third, most clinics require a letter from an independent attorney confirming that each intended parent received legal advice on parental rights before proceeding. Professional guidance, including American Society for Reproductive Medicine ethics committee opinions on third-party reproduction, recommends both psychological evaluation and independent legal counsel in these cases, and clinics operationalize that recommendation by refusing to schedule until the letter is in the chart.
Same-sex couples should plan for one additional layer. The marital presumption that protects a non-birathing spouse in many states does not automatically protect a non-genetic parent in every jurisdiction, so clinics commonly recommend a confirmatory adoption or a state parentage filing (such as California's voluntary parentage declaration process) as belt-and-suspenders documentation. Both intended parents sign the full consent set, and the legal clearance checklist grows accordingly.
Inside a clinic, the new-patient coordinator maintains a legal clearance checklist, and the cycle calendar is not released to medication ordering or billing until every line is checked. Two items dominate the delay statistics in practice. An attorney letter typically takes one to four weeks to produce, because the attorney must review the clinic's specific consent forms. Records from a gamete bank, including screening results and the rights-termination affidavit, commonly take two to six weeks to arrive after a formal request. Either item, sitting incomplete on the checklist, freezes a cycle that is medically ready to start.
Psychological screening is the third node, and it is frequently the last item cleared before a first cycle. Most United States clinics mandate a mental health consultation for recipients of donor gametes, for gamete sources themselves, for patients with a documented history of significant psychiatric illness, and in many programs for patients who have experienced two or three unsuccessful transfers or who are pursuing treatment at an advanced age. The consultation is a clinical gate, and its report is a required chart document.
The interview itself runs sixty to ninety minutes and covers a predictable set of themes: whether the patient understands the procedure and the disposition choices just signed, what coping resources exist if the cycle fails, how any donor-conceived child will be told about their origins, and how the relationship is absorbing the stress of treatment. The psychologist then issues a written report. Scheduling the appointment often takes two to six weeks in a busy practice, and report issuance adds another one to three weeks. The step cannot be compressed by running it in parallel with ovarian stimulation, because clearance must precede the calendar, which makes it the single longest non-compressible wait in the pre-cycle phase. If the interview raises a concern, the psychologist may require a follow-up session or outside counseling, adding further weeks. Booking this appointment at the same time as the initial medical consult is the single most effective scheduling decision a patient can make.
The fourth node is document flow, and it is where international and interstate patients lose the most calendar time. A foreign report does not simply enter your US chart on presentation. Clinics apply acceptance conditions, and each condition has a rejection path.
Patients requesting records from a US provider have a federal right on their side. The HIPAA right of access at 45 CFR 164.524 obligates covered entities to provide copies of records, generally within thirty days of a written request. International requests have no equivalent federal deadline, so patients should file those requests early and follow up weekly.
A representative sequence: records are uploaded at intake; the coordinator's review flags two items, a missing hepatitis B surface antibody result and an uncertified translation; the patient books a local redraw, which takes two weeks including result turnaround; the corrected file is re-reviewed while the attorney letter and psychological report are still pending; the cycle calendar is finally issued. Each flagged item adds two to four weeks. Three flagged items can push a planned cycle back by a full quarter. The prevention is unglamorous and effective: request the clinic's records checklist in writing before traveling, ask which tests the clinic will re-run domestically no matter what, and start the translation and attorney work in parallel with the medical workup.
Once the checklist clears, the familiar medical sequence proceeds: ovarian stimulation with monitoring visits, egg retrieval under sedation, fertilization and embryo culture in the lab, preimplantation genetic testing where chosen, and embryo transfer. A single cycle at a major US clinic generally falls in the range of fifteen to thirty thousand dollars before medication costs, with wide variation by program and services, and published figures from each clinic remain the only reliable reference. From clearance to transfer, the medical steps are well rehearsed; the paperwork described above is where first-cycle timelines are actually won or lost.
Large, standardized programs tend to handle the document chain most predictably. HRC Fertility operates multiple Southern California locations and maintains a standardized consent and clearance workflow, with dedicated staff for international patients whose records require certified translation. CCRM Fertility, headquartered in Colorado with a national network, runs a uniform consent packet across its sites, which makes the disposition clauses consistent from one visit to the next. Shady Grove Fertility, based in Maryland with more than forty locations nationwide, publishes structured new-patient pathways that include the legal and psychological referral steps. When comparing programs, ask each one for its written legal clearance checklist and its psychological referral turnaround time; the answers reveal more about your realistic start date than any marketing page.
Three requests, made early, protect the calendar. Ask for the complete consent packet in advance so the embryo disposition clauses can be read at home, discussed with independent counsel, and corrected before signing day. Ask for the legal clearance checklist specific to your family structure, since married, unmarried, same-sex, and donor gamete cycles carry different document lists. Ask for the next available psychological consultation slot, and book it even if your cycle start date is still tentative. Patients who complete those three steps usually find that the medical tests, the fast part of the process, are the only thing standing between them and a calendar date.
